Daniil Gataulin
Stock Analyst at Chardan Capital
(2.94)
# 1,427
Out of 4,874 analysts
95
Total ratings
40.91%
Success rate
0.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Maintains: Buy | $7 | $1.01 | +593.07% | 12 | Jun 24, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $12.00 | +408.33% | 5 | Jun 24, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $8.47 | +513.93% | 11 | Jun 9, 2025 | |
| QURE uniQure | Maintains: Buy | $38 | $13.87 | +173.97% | 4 | May 30, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $2.55 | +1,194.12% | 7 | May 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $38 → $35 | $6.79 | +415.46% | 4 | May 14, 2025 | |
| CRVO CervoMed | Maintains: Buy | $14 → $15 | $6.65 | +125.56% | 6 | May 12, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $33 | $19.35 | +70.59% | 7 | May 9, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 → $27 | $9.83 | +174.67% | 11 | May 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $8 → $4 | $0.31 | +1,176.73% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 | $16.73 | +318.41% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $0.78 | +410.86% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.80 | +650.00% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $1.68 | +78.57% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.34 | +9,301.71% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.70 | - | 2 | Jul 25, 2023 |
Ocugen
Jun 24, 2025
Maintains: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
Forte Biosciences
Jun 24, 2025
Maintains: Buy
Price Target: $61
Current: $12.00
Upside: +408.33%
REGENXBIO
Jun 9, 2025
Maintains: Buy
Price Target: $52
Current: $8.47
Upside: +513.93%
uniQure
May 30, 2025
Maintains: Buy
Price Target: $38
Current: $13.87
Upside: +173.97%
Adverum Biotechnologies
May 15, 2025
Maintains: Buy
Price Target: $33
Current: $2.55
Upside: +1,194.12%
MeiraGTx Holdings
May 14, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $6.79
Upside: +415.46%
CervoMed
May 12, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $6.65
Upside: +125.56%
Oculis Holding AG
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $19.35
Upside: +70.59%
EyePoint Pharmaceuticals
May 8, 2025
Maintains: Buy
Price Target: $33 → $27
Current: $9.83
Upside: +174.67%
Cognition Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $0.31
Upside: +1,176.73%
May 5, 2025
Maintains: Buy
Price Target: $70
Current: $16.73
Upside: +318.41%
Apr 23, 2025
Maintains: Buy
Price Target: $4
Current: $0.78
Upside: +410.86%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.80
Upside: +650.00%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $1.68
Upside: +78.57%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.34
Upside: +9,301.71%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.70
Upside: -